10
Participants
Start Date
September 30, 2015
Primary Completion Date
December 31, 2016
Study Completion Date
May 31, 2018
Fucosylated MSC for Osteoporosis
"Aproximately 30 days before the infusion of the investigational product, patient bone marrow will be obtained according to standard practice of the Haematology University Hospital Virgen de la Arrixaca (HCUVA).~Mononuclear bone marrow cells will be separated and cultured in GMP conditions to purify and obtain mesenchymal cell established dose range. The infusion day BM-MSCs will be fucosylated and resuspended in saline to a concentration of 5 million cells per 1 mL. Then, the final product will be packaged in syringes for intravenous administration to patients through a peripheral venous access."
Hospital Clínico Virgen de la Arrixaca, El Palmar
Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca
OTHER
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
OTHER
Hospital Universitario Virgen de la Arrixaca
OTHER
Spanish National Health System
OTHER
Public Health Service, Murcia
OTHER
BIONAND, Universidad de Málaga, IBIMA, Ciber-bbn
UNKNOWN
Grupo de Tecnología Sanitaria CIBER-BBN, Inst. Biomecánica de Valencia
UNKNOWN
Red de Terapia Celular
INDUSTRY